Sales, Gross Margin and Profit Delivery
Ahead of Guidance January Sales Growth Trends Accelerating
Sequentially FY23 Revenue and Profit Reaffirmed, with
Increased EPS Guidance Continues to Target Leverage Towards
3x Exiting CY23 Increased FY24 & FY25 Savings To Support
Financial Flexibility and Higher Skincare Investment
Coty Inc. (NYSE: COTY) ("Coty" or "the Company") today announced
its results for the second quarter of fiscal year 2023, ended
December 31, 2022. The Company continued to deliver strong
financial results, maintaining progress across its strategic growth
pillars.
Coty's strong Q2 sales performance came in ahead of
expectations, despite significant industry-wide constraints in key
fragrance components. Q2 sales decreased 3% as reported, fully
driven by a 7% headwind from FX, with sales up 4% on a LFL basis,
which includes approximately 300 bps of negative impact from the
Russia business exit. 1H23 sales declined 1% as reported, while LFL
sales grew 6% including approximately 300 bps of negative impact
from the Russia exit. As a result, 1H23 LFL sales growth for the
core business surpassed the Company's 1H23 guidance of +6-8% LFL
growth, adjusting for the impact of the Russia exit.
During the quarter, consumer demand for beauty products,
particularly prestige fragrances, remained robust, with
high-single-digit growth in the prestige fragrance market and
mid-single-digit growth in the mass beauty market. Although the
Company delivered strong LFL growth across both divisions, as
expected Coty's Prestige revenue and sell-out growth continued to
be constrained by industry-wide component shortages stemming from
accelerated fragrance demand. Encouragingly, the Company has
already begun to see an improvement in its Prestige service levels
entering Q3.
Coty's Prestige business delivered solid performance in Q2 due
to the success of key innovations, even as this year's launch
pipeline was primarily composed of brand extensions. Q2 Prestige
revenues decreased 5% as reported and grew 3% LFL, which included
approximately 300 bps of negative impact from Coty's exit from
Russia. With no signs of slowing in the premiumization trend in
global prestige fragrances, Coty's key fragrance launches reached
top positions, with Burberry Hero EDP ranking as a Top 3
innovation, Boss Bottled Parfum a Top 2, and Gucci Flora Gorgeous
Jasmine as a Top 3 innovation in most key markets. Meanwhile,
Prestige makeup revenues were impacted by the COVID-related total
lockdowns in China. However, Coty continued to drive momentum
outside of China, with particular strength in the U.S., where
retail sales of Gucci makeup and Kylie makeup grew over 40%.
Coty's Consumer Beauty business delivered a strong performance
in Q2, supported by solid market growth and Coty gaining market
share. Consumer Beauty Q2 revenues decreased 1% as reported and
grew 6% LFL, which included approximately 250 bps of negative
impact from Coty's exit from Russia. LFL revenues grew across key
categories, including cosmetics, bodycare, and mass skincare.
During the quarter, the global mass beauty category grew at a
mid-single-digit pace year-on-year, while Coty continued to
outperform the market, delivering a full year of global market
share gains in the portfolio.
Geographically, revenues grew in all regions on a constant
currency basis. EMEA sales declined 10% as reported due to
significant FX headwinds, but grew 2% LFL in Q2 and 6% LFL in 1H23
despite a 5% negative impact from the Russia exit. This solid
growth was fueled by significant Travel Retail momentum and growth
across most markets. Americas sales rose 6% as reported and 8% LFL
driven by strong momentum in Brazil and Latin America, while the
continued strength in U.S. demand was offset by supply constraints.
Asia Pacific sales declined 5% as reported but grew 2% LFL in Q2
and 6% LFL in 1H23, with strong momentum in Asia-ex-China and
Travel Retail, while China revenues were impacted by COVID-related
total lockdowns.
Despite the continued inflationary environment, Coty continued
to generate material gross margin expansion in the quarter, while
also maintaining strong level of media activities to further drive
revenue and sell-out growth. In Q2, reported gross margins expanded
by 110 bps YoY to 65.5%, while adjusted gross margin grew 90 bps
YoY to 65.5%. This solid gross margin expansion was driven by the
full benefit of Coty's pricing execution exiting Q1, enhanced
planning and productivity, and improvements in trade spend. Coty's
Q2 reported operating income of $199.3 million was lower than 2Q22
primarily due to a real estate gain recognized last year.
Meanwhile, adjusted operating income of $261.4 million grew a very
robust 11% YoY despite a high-single-digit headwind from FX.
Adjusted EBITDA of $317.6 million also grew 2% YoY.
During Q2, Coty generated strong free cash flow of $455.1
million, driving Financial Net Debt lower to $3.9 billion at the
end of the quarter. As a result, the financial leverage ratio of
~4.1x exiting Q2 improved sequentially from the <4.5x at the end
of the previous quarter, enabling Coty to achieve its target of
driving leverage towards 4x exiting CY22. The value of Coty's
retained 26% Wella stake increased by approximately $75 million to
$1.04 billion at quarter-end, reflecting a more favorable discount
rate and market multiples. This supported Coty's Economic Net Debt
at approximately $2.8 billion.
Commenting on the operating results, Sue Y. Nabi, Coty's CEO,
said:
"I am incredibly pleased by Coty's tenth consecutive quarter of
delivering results inline to ahead of expectations, especially as
most quarters surpassed expectations despite the highly complex
external environment, with particular pressures this quarter from
component shortages and FX. This delivery validates the strength of
our brands, our teams, and the growing nimbleness of our
organization, positioning us for success in various macro
scenarios.
Coty is firing on all cylinders financially, supported by solid
LFL sales growth, ongoing gross margin and profit expansion, strong
EPS growth, and our ability to reach the critical milestone of 4x
leverage at the end of CY22.
Demand for beauty products remains as strong as ever, fueled by
consumers' desire for self expression, confidence building, and
well-being. We are as confident as ever in our view that beauty
remains a structurally attractive category, that will continue to
outperform global economic growth. As stated before, the "fragrance
index" remains in full force, as consumers turn to fragrances as
mood-boosting and affordable luxuries in an uncertain environment.
As a result, Coty's business should outperform against any slowdown
in global economic growth for three key reasons. First, we are not
yet in the mature phase of our growth evolution, with significant
white space opportunities ahead - including skincare, China, Travel
Retail, and prestige makeup. Secondly, our Prestige division
remains protected by our affordable luxury beauty offerings
relative to much more expensive luxury goods. And finally, our
Consumer Beauty business continues to perform from a position of
strength, consistently offering consumers value through
high-quality and desirable beauty products at an affordable
price.
Against this backdrop, we are delivering on our balanced growth
agenda, with solid LFL growth across both divisions, all regions,
and each of our key categories including fragrances, cosmetics, and
bodycare.
In Prestige, we continue to grow the fragrance category and
premiumize our portfolio through our brands' iconic pillars and
market-leading premium launches, such as Burberry Hero and Her,
Gucci Flora Gorgeous Jasmine and Gorgeous Gardenia, Boss Bottled
Parfum and Chloe Atelier des Fleurs. I am pleased with the
performance we have delivered in our prestige fragrance business
year-to-date, despite supply constraints, an innovation pipeline
consisting of primarily brand extensions, and continued tight
control on value distribution. At the same time, we have robust
plans underway to accelerate our skincare business, including the
upcoming launch of Lancaster's ultra premium skincare line Ligne
Princiere in China, as well as new products and omnichannel
activations behind the new philosophy platform.
In Consumer Beauty, we have delivered global market share gains
over the past year, and I am excited about the initiatives still to
come across our key brands.
As we continue to deliver on our strategic and financial
objectives, we have identified additional savings projects for both
FY24 and FY25. We now target $90 million of savings in FY24, a $15
million increase from our previous target, and an additional $75
million in FY25. These savings will protect our profit and cash
delivery under a variety of macroeconomic scenarios, while
simultaneously supporting a significant step-up in investments
behind our strategically critical skincare pillar.
In our social agenda, we launched the #Undefine Beauty campaign,
calling on English-language dictionary publishers to update their
definitions of 'beauty' so that no one feels excluded by the
definition or the examples that accompany it. This is an important
step in our organizational purpose, "together, we unleash every
vision of beauty."
In sum, I am as energized as ever by the continued resilience of
the beauty market; Coty's balanced portfolio covering key
categories, channels, and markets; the substantial white space
opportunities ahead of us in skincare, China and Travel Retail; and
Coty's culture of fearless kindness to promote positive change both
inside and outside the company. We continue on our journey to
transform Coty into a true beauty powerhouse."
*Adjusted financial metrics used in this
release are non-GAAP. See reconciliations of GAAP results to
Adjusted results in the accompanying tables.
Highlights
- 2Q23 and 1H23 net revenue trends were driven by high single
digit LFL growth in both Prestige and Consumer Beauty, excluding
the impact from Coty's exit from Russia.
- 2Q23 reported operating income totaled $199.3 million in 2Q23
and 1H23 reported operating income totaled $371.2 million.
- 2Q23 adjusted operating income increased 11% to $261.4 million
and 1H23 adjusted operating income grew 17% to $511.0 million, with
the adjusted operating margin increasing by over 200 bps to over
17%.
- 2Q23 adjusted EBITDA grew 2% to $317.6 million and 1H23
adjusted EBITDA grew 6% to $625.5 million, driving a year-to-date
adjusted EBITDA margin of 21.5%, up 150 bps.
- 2Q23 reported EPS was $0.27 and 1H23 reported EPS was
$0.42.
- 2Q23 adjusted EPS totaled $0.22, with the 1H23 adjusted EPS of
$0.33 increasing $0.07 or 27% from the prior year, including a
$0.01 EPS benefit from the mark-to-market on the equity swap.
- Savings totaled approximately $50M in Q2 and approximately $70
million in 1H23, with a clear roadmap to reach savings of
approximately $170 million in FY23. Coty now targets savings of
roughly $90 million in FY24, a $15 million increase from its
previous target, with a new savings target of approximately $75
million in FY25.
- 2Q23 free cash flow was strong at $455.1 million, bringing the
year-to-date total to $543.3 million.
- Financial Net Debt was $3.9 billion and Economic Net Debt
totaled $2.8 billion at quarter end, resulting in financial
leverage of approximately 4.1x, inline with guidance.
- During the quarter, Coty entered a second equity swap agreement
with several banks to hedge a targeted share buyback program of
approximately $200 million in CY25
Outlook
Coty continues to see strong demand growth across nearly all
markets, particularly in Prestige fragrances, with Coty maintaining
strong launch activity in both Prestige and Consumer Beauty. At the
same time, the component shortages which limited Coty's Prestige
fragrance growth in Q2 have begun to ease, including a sequential
improvement in January service levels. The combination of improved
service levels and ongoing strength in beauty consumption is
driving a sequential acceleration in Coty’s January sales growth.
These trends underpin the Company's confidence in its FY23 outlook,
which is inline with its medium term growth algorithm.
Coty continues to target FY23 adjusted EBITDA of $955-965M based
on current FX rates, relatively in-line with its medium term growth
target of +9-11%, adjusting for the impact of the Russia exit.
Supported by strong EPS delivery in 1H23, Coty now expects FY23
adjusted EPS growth of over 20% to $0.35-0.36, an increase from its
previous adjusted EPS guidance of $0.32-0.33, excluding any
mark-to-market adjustments on the equity swap and assumes no
significant changes in the current tax regulations. The Company
continues to anticipate adjusted EPS growth of approximately 20% in
FY24 and beyond fueled by lower interest expenses as part of its
deleveraging efforts, consistent with its medium-term targets.
Coty continues to expect FY23 revenues for the core business,
adjusting for the impact of the Russia exit, to grow 6-8% LFL, with
revenue growth trends in 2H23 consistent with this range. The exit
from Russia is estimated to negatively impact FY23 sales by
approximately 2%, including an approximate 2% impact in Q3 and none
in Q4. Based on current exchange rates, the Company now anticipates
FX headwinds towards the better end of its prior outlook of -6-8%.
This FX outlook includes a mid-single-digit negative impact on
sales in Q3 and a low-single-digit negative impact in Q4.
Coty continues to expect modest gross margin expansion in FY23,
despite the elevated inflationary environment, aided by savings as
well as solid pricing execution, including mid-single-digit pricing
increases exiting Q1 and another round of mid-single-digit pricing
going into effect exiting Q3.
In addition, the Company continues to target leverage towards 3x
exiting CY23 and approximately 2x exiting CY25.
Financial Results*
Refer to “Non-GAAP Financial Measures” for discussion of the
non-GAAP financial measures used in this release; reconciliations
from reported to adjusted results can be found at the end of this
release.
Revenues:
- 2Q23 reported net revenues of $1,523.6 million decreased 3%
year-over-year, including a negative foreign exchange (FX) impact
of 7%. LFL revenue increased 4%, driven by a 3% increase in
Prestige and a 6% increase in Consumer Beauty. The exit from Russia
represented ~3% headwind to total Coty LFL, including ~3% headwind
to Prestige and ~2% to Consumer Beauty LFL.
- Year-to-date reported net revenues of $2,913.6 million
decreased 1% year-over-year, including a negative FX impact of 7%.
LFL revenue increased 6%, driven by a 5% increase in Prestige and a
9% increase in Consumer Beauty. The exit from Russia represented
~2% headwind to total Coty LFL as well as a ~3% headwind to
Prestige and ~2% headwind to Consumer Beauty LFL.
Gross Margin:
- 2Q23 reported gross margin of 65.5% increased from 64.4% in the
prior-year period, while adjusted gross margin of 65.5% increased
by 90 basis points from 64.6% in 2Q22. The increase was driven by
pricing and improved trade spend, partially offset by COGS
inflation.
- Year-to-date reported gross margin of 64.8% increased from
63.9%, while adjusted gross margin of 64.8% increased by 80 bps
year-on-year. The increase was driven by pricing and improved trade
spend, partially offset by COGS inflation.
Operating Income and EBITDA:
- 2Q23 reported operating income of $199.3 million declined from
a reported operating income of $244.0 million in the prior year due
to the non-recurrence of a gain on the sale of real estate
recognized in the prior year.
- 2Q23 adjusted operating income of $261.4 million rose 11% from
$236.3 million in the prior year, despite an 7% negative impact
from FX, driven by a $19.4 million reduction in depreciation
expense. The adjusted EBITDA of $317.6 million increased 2% from
the prior year. For 2Q23, the adjusted operating margin was 17.2%,
a strong increase of 220 bps YoY while the adjusted EBITDA margin
was 20.8%, increasing 100 bps YoY.
- Year-to-date reported operating income of $371.2 million
increased from $261.2 million due to a reduction in stock based
compensation and depreciation expense. Year-to-date adjusted
operating income increased 17% to $511.0 million, with a margin of
17.5% reflecting 270 bps of margin expansion YoY, while the
adjusted EBITDA totaled $625.5 million with a margin of 21.5%.
Net Income:
- 2Q23 reported net income of $235.0 million increased from a net
income of $188.9 million in the prior year, due to higher
Convertible Series B Preferred Stock dividends in the prior year, a
decrease in the tax provision, and amortization expense, partially
offset by a higher benefit in the prior year from a change in
Wella's fair value.
- The 2Q23 adjusted net income of $191.9 million increased from
$147.7 million in the prior year period, primarily reflecting the
benefit from the mark-to-market on the equity swap.
- Year-to-date reported net income of $360.3 million increased
from $291.9 million in the prior year period. Year-to-date adjusted
net income of $284.6 million increased from $210.8 million in the
prior year.
Earnings Per Share (EPS) - diluted:
- 2Q23 reported earnings per share of $0.27 increased from a
reported earnings per share of $0.23 in the prior year due to the
increase in reported net income.
- 2Q23 adjusted EPS of $0.22 improved from $0.17 in the prior
year due to the improvement in adjusted net income, primarily
reflecting a $0.05 benefit from the mark-to-market on the equity
swap.
- Year-to-date earnings per share of $0.42 increased from $0.36
in the prior year.
- Year-to-date adjusted EPS of $0.33 increased from $0.26 in the
prior year driven by growth in adjusted operating income, with a
$0.01 benefit from the mark-to-market on the equity swap.
Operating Cash Flow:
- 2Q23 cash from operations totaling $482.2 million increased
from $449.0 million in the prior-year period, reflecting higher net
income on a cash basis and working capital benefits. First half
cash from operations $645.4 million.
- 2Q23 free cash flow of $455.1 million increased from a free
cash flow of $408.0 million in the prior year driven by the $33.2
million increase in operating cash flow and a $13.9 decrease in
capex. First half free cash flow totaled $543.3 million.
Financial Net Debt:
- Financial Net Debt of $3,857.1 million on December 31, 2022,
decreased from $4,191.4 million on September 30, 2022, driven by
the free cash flow generation.
Second Quarter Business Review by
Segment*
Prestige
In 2Q23, Prestige net revenues of $957.7 million or 63% of Coty
sales, decreased by 5% on a reported basis versus the prior year,
due to 8% negative FX impact. On a LFL basis, Prestige net revenues
delivered growth of 3%, which includes approximately 300 bps of
negative impact from the Russia exit, driven by strength across all
regions including continued recovery in most EMEA markets, Travel
Retail, Latin America, and most APAC markets.
During Q2, the Prestige fragrance category across North America
and Europe continued to experience strong demand, though this
constrained by the industry's shortage of glass and certain other
components. Overall, category sell-out growth remained solid,
rising high single digits versus last year and close to 30% versus
2019 levels reflecting momentum in both North America and Europe.
At the same time, global Travel Retail trends remained robust
across all regions with close to 40% growth in both Q2 and 1H23 ,
supported by the continued recovery of travel and heightened beauty
consumption. Importantly, Coty's recent innovations of Burberry
Hero EDP and Burberry Her Elixir De Parfum, Hugo Boss Bottled
Parfum, and Gucci Flora Gorgeous Jasmine continued to deliver very
strong performances during the quarter, reaching top ranks across
key markets. Prestige cosmetics consumption was robust in markets
like the U.S., where both Gucci and Kylie cosmetics grew over 40%,
reflecting 3x the market level.
The Prestige segment generated a reported operating income of
$164.4 million in 2Q23, compared to $141.6 million in the prior
year. The 2Q23 adjusted operating income was $201.7 million, up
from an adjusted operating income of $182.0 million in the prior
year, driven by strong gross margin improvement. Adjusted EBITDA
for the Prestige segment rose to $228.5 million from $219.0 million
in the prior year, with a margin of 23.9%, up 220 bps YoY.
Consumer Beauty
In 2Q23, Consumer Beauty net revenues of $565.9 million, or 37%
of Coty sales, decreased by 1% as reported versus the prior year,
due to 7% negative FX impact. On a LFL basis, Consumer Beauty net
revenues rose 6%, which includes approximately 250 bps of negative
impact from the Russia exit. The strong LFL growth was driven by
strong performance across color cosmetics, body care, and skincare.
Encouragingly, all regions generated LFL growth in the quarter.
During the quarter, the total Coty Consumer Beauty business
continued to gain market share globally resulting in a full year of
market share gains. Coty saw strong momentum in Q2 and year-to-date
in most of its key brands, with single digit to double digit
revenue growth across CoverGirl, Rimmel, Max Factor, adidas, and
Monange, fueled by improving shelf productivity, impactful
innovations and pricing execution.
The Consumer Beauty reported operating income was $49.4 million
in 2Q23, an increase from $43.3 million in the prior year. The 2Q23
adjusted operating income of $59.7 million increased from adjusted
operating income of $54.3 million in the prior year, resulting in
100 bps of margin expansion to 10.5%. During the quarter, adjusted
EBITDA decreased to $89.1 million from $92.9 million in the prior
year, with a margin of 15.7%.
Second Quarter Fiscal 2023 Business
Review by Region*
Americas
- In 2Q23, Americas net revenues of $624.3 million, or 41% of
Coty sales, increased 6% as reported and 8% LFL. This was driven by
growth of both Prestige and Consumer Beauty. The Prestige
performance was fueled by growth across nearly all countries, with
particularly strong growth throughout most Latin American markets
and Travel Retail, and more moderate growth within the U.S.
Prestige business due to fragrance component shortages. Meanwhile,
in Consumer Beauty, nearly every country delivered growth. The
overall performance was also supported by strong performance from
recent innovations during the quarter including Gucci Flora
Gorgeous Jasmine, Marc Jacobs Daisy Ever So Fresh, Burberry Hero
EDP, and Burberry Her Elixir De Parfum on the Prestige side, and
CoverGirl Simply Ageless Triple Action concealer in Consumer
Beauty.
EMEA
- In 2Q23, EMEA net revenues of $713.5 million, or 47% of Coty
sales, decreased 10% as reported driven by FX, but grew 2% LFL. The
exit from Russia negatively impacted LFL sales by approximately 500
bps. The performance was driven by strong increases in both
Prestige and Consumer Beauty across most markets, with particularly
strong momentum in regional Travel Retail.
Asia Pacific
- In 2Q23, Asia Pacific net revenues of $185.8 million, or 12% of
Coty sales, decreased 5% as reported but grew 2% LFL. Consumer
Beauty delivered solid growth, while Prestige was impacted by the
COVID-related restrictions in China during much of the quarter.
Excluding China, nearly all markets delivered double-digit growth
during the quarter.
Noteworthy Company
Developments
Other noteworthy company developments include:
- On November 15, 2022, Coty released its Sustainability Report
for the 2022 fiscal year, which outlines the progress made in
advancing Coty's corporate sustainability strategy, Beauty that
Lasts. While a complete view of Coty's sustainability activities in
FY22 can be found in the full report, Coty announced its near-term
reduction targets for greenhouse gas emissions were approved by
SBTi.
- On November 23, 2022, Coty announced the early tender results
of its previously announced series of tender offers.
- On December 12, 2022, Coty announced its intention to further
gradually reintroduce capital returns as deleveraging continues,
while also entering into agreements with several banks to start
hedging a potential share buyback program of approximately $200
million in calendar 2025. This program adds to the Company's
previously announced $200 million hedged buyback program in
CY24.
- On December 20, 2022 Coty and HUGO BOSS announced the renewal
of their license agreement, which has now been extended beyond
2035, and includes all BOSS and HUGO fragrances for men and women.
Following the Hugo Boss license renewal, Coty has no sizeable
license up for renewal in the next six years. The average remaining
duration of Coty's top six licenses, which together account for
over 80% of Coty's prestige fragrance business, is now
approximately ten years.
- On December 21, 2022, Coty announced the sale of its Lacoste
fragrance license back to Lacoste by mutual agreement.
- On January 6, 2023, Coty announced the appoint of Lubomira
Rochet to its Board of Directors, effective January 2, 2023.
Lubomira Rochet is a Partner at JAB Holding Company and brings over
twenty years of experience in business and digital transformation.
She previously served as Chief Digital Office and member of the
Executive Committee at L'Oreal for seven years.
Conference Call
Coty Inc. will issue pre-recorded remarks at approximately 7:20
AM (ET) today, February 8, 2023 and will hold a live question and
answer session beginning at 8:15 AM (ET). The pre-recorded remarks
and live question and answer session will be available at
http://investors.coty.com. The dial-in number for the live question
and answer session is (800) 579-2543 in the U.S. or (785) 424-1789
internationally (conference passcode number: COTY2Q23).
About Coty Inc.
Founded in Paris in 1904, Coty is one of the world’s largest
beauty companies with a portfolio of iconic brands across
fragrance, color cosmetics, and skin and body care. Coty serves
consumers around the world, selling prestige and mass market
products in more than 130 countries and territories. Coty and our
brands empower people to express themselves freely, creating their
own visions of beauty; and we are committed to making a positive
impact on the planet. Learn more at coty.com or on LinkedIn and
Instagram.
Forward Looking
Statements
Certain statements in this Earnings Release are “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements reflect the
Company's current views with respect to, among other things,
strategic planning, targets and outlook for future reporting
periods (including the extent and timing of revenue, expense and
profit trends and changes in operating cash flows and cash flows
from operating activities and investing activities), the wind down
of the Company’s operations in Russia (including timing and
expected impact), the Company’s future operations and strategy
(including the expected implementation and related impact of its
strategic priorities), ongoing and future cost efficiency,
optimization and restructuring initiatives and programs, strategic
transactions (including their expected timing and impact),
expectations and/or plans with respect to joint ventures (including
Wella and the timing and size of any related distribution or return
of capital), the Company’s capital allocation strategy and payment
of dividends (including suspension of dividend payments and the
duration thereof and any plans to resume cash dividends on common
stock or to continue to pay dividends in cash on preferred stock),
investments, licenses and portfolio changes, product launches,
relaunches or rebranding (including the expected timing or impact
thereof), synergies, savings, performance, cost, timing and
integration of acquisitions, future cash flows, liquidity and
borrowing capacity (including any refinancing or deleveraging
activities), timing and size of cash outflows and debt
deleveraging, the timing and extent of any future impairments, and
synergies, savings, impact, cost, timing and implementation of the
Company’s ongoing transformation agenda (including operational and
organizational structure changes, operational execution and
simplification initiatives, fixed cost reductions and supply chain
changes), the expected impact, cost, timing and implementation of
e-commerce and digital initiatives, the expected impact, cost,
timing and implementation of sustainability initiatives (including
progress, plans and goals), the impact of COVID-19, the expected
impact of geopolitical risks including the ongoing war in Ukraine
on our business operations, sales outlook and strategy, the
expected impact of global supply chain challenges and/or
inflationary pressures (including as a result of COVID-19 and/or
the war in Ukraine) and expectations regarding future service
levels, and the priorities of senior management. These
forward-looking statements are generally identified by words or
phrases, such as “anticipate”, “are going to”, “estimate”, “plan”,
“project”, “expect”, “believe”, “intend”, “foresee”, “forecast”,
“will”, “may”, “should”, “outlook”, “continue”, “temporary”,
“target”, “aim”, “potential”, “goal” and similar words or phrases.
These statements are based on certain assumptions and estimates
that we consider reasonable, but are subject to a number of risks
and uncertainties, many of which are beyond our control, which
could cause actual events or results (including our financial
condition, results of operations, cash flows and prospects) to
differ materially from such statements, including risks and
uncertainties relating to:
- the Company’s ability to successfully implement its
transformation agenda and compete effectively in the beauty
industry, achieve the benefits contemplated by its strategic
initiatives (including revenue growth, cost control, gross margin
growth and debt deleveraging) and successfully implement its
strategic priorities (including stabilizing its consumer beauty
brands through leading innovation and improved execution,
accelerating its prestige fragrance brands and ongoing expansion
into prestige cosmetics, building a comprehensive skincare
portfolio, enhancing its e-commerce and direct-to-consumer
capabilities, and expanding its presence in China through prestige
products and select consumer beauty brands, and establishing Coty
as an industry leader in sustainability) in each case within the
expected time frame or at all;
- the Company’s ability to anticipate, gauge and respond to
market trends and consumer preferences, which may change rapidly,
and the market acceptance of new products, including new products
related to Kylie Jenner’s or Kim Kardashian West’s existing beauty
businesses, any relaunched or rebranded products and the
anticipated costs and discounting associated with such relaunches
and rebrands, and consumer receptiveness to our current and future
marketing philosophy and consumer engagement activities (including
digital marketing and media);
- use of estimates and assumptions in preparing the Company’s
financial statements, including with regard to revenue recognition,
income taxes (including the expected timing and amount of the
release of any tax valuation allowance), the assessment of
goodwill, other intangible and long-lived assets for impairments,
the market value of inventory, the fair value of the equity
investment, and the fair value of acquired assets and liabilities
associated with acquisitions;
- the impact of any future impairments;
- managerial, transformational, operational, regulatory, legal
and financial risks, including diversion of management attention to
and management of cash flows, expenses and costs associated with
the Company's response to COVID-19, the Company's transformation
agenda, its global business strategies, the integration of the
strategic partnerships with Kylie Jenner and Kim Kardashian West,
and future strategic initiatives, and, in particular, the Company's
ability to manage and execute many initiatives simultaneously
including any resulting complexity, employee attrition or diversion
of resources;
- the timing, costs and impacts of divestitures and the amount
and use of proceeds from any such transactions;
- future divestitures and the impact thereof on, and future
acquisitions, new licenses and joint ventures and the integration
thereof with, our business, operations, systems, financial data and
culture and the ability to realize synergies, manage supply chain
challenges and avoid future supply chain and other business
disruptions, reduce costs (including through the Company’s cash
efficiency initiatives), avoid liabilities and realize potential
efficiencies and benefits (including through our restructuring
initiatives) at the levels and at the costs and within the time
frames contemplated or at all;
- increased competition, consolidation among retailers, shifts in
consumers’ preferred distribution and marketing channels (including
to digital and prestige channels), distribution and shelf-space
resets or reductions, compression of go-to-market cycles, changes
in product and marketing requirements by retailers, reductions in
retailer inventory levels and order lead-times or changes in
purchasing patterns, impact from COVID-19 on retail revenues, and
other changes in the retail, e-commerce and wholesale environment
in which the Company does business and sells its products and the
Company’s ability to respond to such changes (including its ability
to expand its digital, direct-to-consumer and e-commerce
capabilities within contemplated timeframes or at all);
- the Company and its joint ventures’, business partners’ and
licensors’ abilities to obtain, maintain and protect the
intellectual property used in its and their respective businesses,
protect its and their respective reputations (including those of
its and their executives or influencers), public goodwill, and
defend claims by third parties for infringement of intellectual
property rights;
- any change to the Company’s capital allocation and/or cash
management priorities, including any change in the Company’s
dividend policy;
- any unanticipated problems, liabilities or integration or other
challenges associated with a past or future acquired business,
joint ventures or strategic partnerships which could result in
increased risk or new, unanticipated or unknown liabilities,
including with respect to environmental, competition and other
regulatory, compliance or legal matters, and specifically in
connection with the strategic partnerships with Kylie Jenner and
Kim Kardashian, risks related to the entry into a new distribution
channel, the potential for channel conflict, risks of retaining
customers and key employees, difficulties of integration (or the
risks associated with limiting integration),ability to protect
trademarks and brand names, litigation or investigations by
governmental authorities, and changes in law, regulations and
policies that affect KKW Holdings, LLC’s (“KKW Holdings”) business
or products, including risk that direct selling laws and
regulations may be modified, interpreted or enforced in a manner
that results in a negative impact to KKW Holdings’ business model,
revenue, sales force or business;
- the Company’s international operations and joint ventures,
including enforceability and effectiveness of its joint venture
agreements and reputational, compliance, regulatory, economic and
foreign political risks, including difficulties and costs
associated with maintaining compliance with a broad variety of
complex local and international regulations;
- the Company’s dependence on certain licenses (especially in the
fragrance category) and the Company’s ability to renew expiring
licenses on favorable terms or at all;
- the Company’s dependence on entities performing outsourced
functions, including outsourcing of distribution functions, and
third-party manufacturers, logistics and supply chain suppliers,
and other suppliers, including third-party software providers,
web-hosting and e-commerce providers;
- administrative, product development and other difficulties in
meeting the expected timing of market expansions, product launches,
re-launches and marketing efforts, including in connection with new
products related to Kylie Jenner’s or Kim Kardashian West’s
existing beauty businesses or new products related to Orveda;
- changes in the demand for the Company’s products due to
declining or depressed global or regional economic conditions, and
declines in consumer confidence or spending, whether related to the
economy (such as austerity measures, tax increases, high fuel
costs, or higher unemployment), wars, natural or other disasters,
weather, pandemics, security concerns, terrorist attacks or other
factors;
- global political and/or economic uncertainties, disruptions or
major regulatory or policy changes, and/or the enforcement thereof
that affect the Company’s business, financial performance,
operations or products, including the impact of the war in Ukraine
and any escalation or expansion thereof, Brexit (and related
business or market disruption), recent elections in Brazil, the
current U.S. administration and mid-term elections, changes in the
U.S. tax code, and recent changes and future changes in tariffs,
retaliatory or trade protection measures, trade policies and other
international trade regulations in the U.S., the European Union and
Asia and in other regions where the Company operates; recent and
future changes in sanctions regulations including in connection
with the war in Ukraine and any escalation or expansion
thereof;
- currency exchange rate volatility and currency devaluation
and/or inflation;
- the number, type, outcomes (by judgment, order or settlement)
and costs of current or future legal, compliance, tax, regulatory
or administrative proceedings, investigations and/or litigation,
including product liability cases (including asbestos and
talc-related litigation for which indemnities and/or insurance may
not be available), distributor or licensor litigation, and
compliance, litigation or investigations relating to the Company's
joint ventures or strategic partnerships;
- the Company’s ability to manage seasonal factors and other
variability and to anticipate future business trends and
needs;
- the impact of COVID-19 (or future similar events), including
demand for the Company’s products, illness, quarantines, government
actions, facility closures, store closures or other restrictions in
connection with the COVID-19 pandemic, and the extent and duration
thereof, related impact on the Company's ability to meet customer
needs and on the ability of third parties on which the Company
relies, including its suppliers, customers, contract manufacturers,
distributors, contractors, commercial banks and joint-venture
partners, to meet their obligations to the Company, in particular
collections from customers, and the ability to successfully
implement measures to respond to such impacts;
- disruptions in the availability and distribution of raw
materials and components needed to manufacture the Company's
products;
- disruptions in operations, sales and in other areas, including
due to disruptions in our supply chain, restructurings and other
business alignment activities, manufacturing or information
technology systems, labor disputes, extreme weather and natural
disasters, impact from COVID-19 or similar global public health
events, the outbreak of war or hostilities (including the war in
Ukraine and any escalation or expansion thereof), impact of global
supply chain challenges, and the impact of such disruptions on the
Company’s ability to generate profits, stabilize or grow revenues
or cash flows, comply with its contractual obligations and
accurately forecast demand and supply needs and/or future
results;
- the Company's ability to adapt its business to address climate
change concerns and to respond to increasing governmental and
regulatory measures relating to environmental, social and
governance matters, including expanding mandatory and voluntary
reporting, diligence and disclosure, as well as new taxes
(including on energy and plastic), and the impact of such measures
on its costs, business operations and strategy;
- restrictions imposed on the Company through its license
agreements, credit facilities and senior unsecured bonds or other
material contracts, its ability to generate cash flow to repay,
refinance or recapitalize debt and otherwise comply with its debt
instruments, and changes in the manner in which the Company
finances its debt and future capital needs;
- increasing dependency on information technology, including as a
result of remote working in response to COVID-19, and the Company’s
ability to protect against service interruptions, data corruption,
cyber-based attacks or network security breaches, including
ransomware attacks, costs and timing of implementation and
effectiveness of any upgrades or other changes to information
technology systems, and the cost of compliance or the Company’s
failure to comply with any privacy or data security laws (including
the European Union General Data Protection Regulation, the
California Consumer Privacy Act and similar state laws, the Brazil
General Data Protection Law, and the China Data Security Law and
Personal Information Protection Law) or to protect against theft of
customer, employee and corporate sensitive information;
- the Company's ability to attract and retain key personnel and
the impact of senior management transitions and organizational
structure changes;
- the distribution and sale by third parties of counterfeit
and/or gray market versions of the Company’s products;
- the impact of the Company's transformation agenda on the
Company’s relationships with key customers and suppliers and
certain material contracts;
- the Company’s relationship with JAB Beauty B.V. (formerly known
as Cottage Holdco B.V.), as the Company’s majority stockholder, and
its affiliates, and any related conflicts of interest or
litigation;
- the Company’s relationship with KKR, whose affiliate KKR Bidco
is an investor in the Wella Business, and any related conflicts of
interest or litigation;
- future sales of a significant number of shares by the Company’s
majority stockholder or the perception that such sales could occur;
and
- other factors described elsewhere in this document and in
documents that the Company files with the SEC from time to
time.
When used herein, the term “includes” and “including” means,
unless the context otherwise indicates, “including without
limitation”. More information about potential risks and
uncertainties that could affect the Company’s business and
financial results is included under the heading “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and
Results of Operations” in the Company’s Annual Report on Form 10-K
for the year ended June 30, 2022 and other periodic reports the
Company has filed and may file with the SEC from time to time.
All forward-looking statements made in this release are
qualified by these cautionary statements. These forward-looking
statements are made only as of the date of this release, and the
Company does not undertake any obligation, other than as may be
required by applicable law, to update or revise any forward-looking
or cautionary statements to reflect changes in assumptions, the
occurrence of events, unanticipated or otherwise, or changes in
future operating results over time or otherwise.
Comparisons of results for current and any prior periods are not
intended to express any future trends or indications of future
performance unless expressed as such, and should only be viewed as
historical data.
Non-GAAP Financial
Measures
The Company operates on a global basis, with the majority of net
revenues generated outside of the U.S. Accordingly, fluctuations in
foreign currency exchange rates can affect results of operations.
Therefore, to supplement financial results presented in accordance
with GAAP, certain financial information is presented excluding the
impact of foreign currency exchange translations to provide a
framework for assessing how the underlying businesses performed
excluding the impact of foreign currency exchange translations
(“constant currency”). Constant currency information compares
results between periods as if exchange rates had remained constant
period-over-period, with the current period’s results calculated at
the prior-year period’s rates. The Company calculates constant
currency information by translating current and prior-period
results for entities reporting in currencies other than U.S.
dollars into U.S. dollars using constant foreign currency exchange
rates. The constant currency calculations do not adjust for the
impact of revaluing specific transactions denominated in a currency
that is different to the functional currency of that entity when
exchange rates fluctuate. The constant currency information
presented may not be comparable to similarly titled measures
reported by other companies. The Company discloses the following
constant currency financial measures: net revenues, organic
like-for-like (LFL) net revenues, adjusted gross profit and
adjusted operating income.
The Company presents period-over-period comparisons of net
revenues on a constant currency basis as well as on an organic
(LFL) basis. The Company believes that organic (LFL) better enables
management and investors to analyze and compare the Company's net
revenues performance from period to period. For the periods
described in this release, the term “like-for-like” describes the
Company's core operating performance, excluding the financial
impact of (i) acquired brands or businesses in the current year
period until we have twelve months of comparable financial results,
(ii) the divested brands or businesses or early terminated brands,
generally, in the prior year non-comparable periods, to maintain
comparable financial results with the current fiscal year period
and (iii) foreign currency exchange translations to the extent
applicable. For a reconciliation of organic (LFL)
period-over-period, see the table entitled “Reconciliation of
Reported Net Revenues to Like-For-Like Net Revenues”.
The Company presents operating income, operating income margin,
gross profit, gross margin, effective tax rate, net income, net
income margin, net revenues, EBITDA, and EPS (diluted) on a
non-GAAP basis and specifies that these measures are non-GAAP by
using the term “adjusted” (collectively the Adjusted Performance
Measures). The reconciliations of these non-GAAP financial measures
to the most directly comparable financial measures calculated and
presented in accordance with GAAP are shown in tables below. These
non-GAAP financial measures should not be considered in isolation
from, or as a substitute for or superior to, financial measures
reported in accordance with GAAP. Moreover, these non-GAAP
financial measures have limitations in that they do not reflect all
the items associated with the operations of the business as
determined in accordance with GAAP. Other companies, including
companies in the beauty industry, may calculate similarly titled
non-GAAP financial measures differently than we do, limiting the
usefulness of those measures for comparative purposes.
Adjusted operating income/Adjusted EBITDA from continuing
operations excludes restructuring costs and business structure
realignment programs, amortization, acquisition- and
divestiture-related costs and acquisition accounting impacts,
stock-based compensation, and asset impairment charges and other
adjustments as described below. For adjusted EBITDA, in addition to
the preceding, we exclude the adjusted depreciation as defined
below. We do not consider these items to be reflective of our core
operating performance due to the variability of such items from
period-to-period in terms of size, nature and significance. They
are primarily incurred to realign our operating structure and
integrate new acquisitions, and exclude divestitures, and fluctuate
based on specific facts and circumstances. Additionally, Adjusted
net income attributable to Coty Inc. and Adjusted net income
attributable to Coty Inc. per common share are adjusted for certain
interest and other (income) expense and deemed preferred stock
dividends, as described below, and the related tax effects of each
of the items used to derive Adjusted net income as such charges are
not used by our management in assessing our operating performance
period-to-period.
Adjusted Performance Measures reflect adjustments based on the
following items:
- Costs related to acquisition and divestiture activities: The
Company has excluded acquisition- and divestiture-related costs and
the accounting impacts such as those related to transaction costs
and costs associated with the revaluation of acquired inventory in
connection with business combinations because these costs are
unique to each transaction. Additionally, for divestitures, the
Company excludes write-offs of assets that are no longer
recoverable and contract related costs due to the divestiture. The
nature and amount of such costs vary significantly based on the
size and timing of the acquisitions and divestitures, and the
maturities of the businesses being acquired or divested. Also, the
size, complexity and/or volume of past transactions, which often
drives the magnitude of such expenses, may not be indicative of the
size, complexity and/or volume of any future acquisitions or
divestitures.
- Restructuring and other business realignment costs: The Company
has excluded the costs associated with restructuring and business
structure realignment programs to allow for comparable financial
results to historical operations and forward-looking guidance. In
addition, the nature and amount of such charges vary significantly
based on the size and timing of the programs. By excluding the
referenced expenses from the non-GAAP financial measures,
management is able to further evaluate the Company's ability to
utilize existing assets and estimate their long-term value.
Furthermore, our management believes that the adjustment of these
items supplements the GAAP information with a measure that can be
used to assess the sustainability of operating performance.
- Asset impairment charges: The Company has excluded the impact
of asset impairments as such non-cash amounts are inconsistent in
amount and frequency and are significantly impacted by the timing
and/or size of acquisitions. Our management believes that the
adjustment of these items supplements the GAAP information with a
measure that can be used to assess the sustainability of our
operating performance.
- Amortization expense: The Company has excluded the impact of
amortization of finite-lived intangible assets, as such non-cash
amounts are inconsistent in amount and frequency and are
significantly impacted by the timing and/or size of acquisitions.
Our management believes that the adjustment of these items
supplements the GAAP information with a measure that can be used to
assess the sustainability of our operating performance. Although we
exclude amortization of intangible assets from our non-GAAP
expenses, our management believes that it is important for
investors to understand that such intangible assets contribute to
revenue generation. Amortization of intangible assets that relate
to past acquisitions will recur in future periods until such
intangible assets have been fully amortized. Any future
acquisitions may result in the amortization of additional
intangible assets.
- Costs related to market exit: The Company has excluded the
impact of direct incremental costs related to our decision to wind
down our business operations in Russia. We believe that these
direct and incremental costs are inconsistent and infrequent in
nature. Consequently, our management believes that the adjustment
of these items supplements the GAAP information with a measure that
can be used to assess the sustainability of our operating
performance.
- Gains on sale of real estate: The Company has excluded the
impact of Gains on sale of real estate as such amounts are
inconsistent in amount and frequency and are significantly impacted
by the size of the sale. Our management believes that the
adjustment of these items supplements the GAAP information with a
measure that can be used to assess the sustainability of our
operating performance.
- Stock-based compensation: Although stock-based compensation is
a key incentive offered to our employees, we have excluded the
effect of these expenses from the calculation of adjusted operating
income and adjusted EBITDA. This is due to their primarily non-cash
nature; in addition, the amount and timing of these expenses may be
highly variable and unpredictable, which may negatively affect
comparability between periods.
- Depreciation and Adjusted depreciation: Our adjusted operating
income excludes the impact of accelerated depreciation for certain
restructuring projects that affect the expected useful lives of
Property, Plant and Equipment, as such charges vary significantly
based on the size and timing of the programs. Further, we have
excluded adjusted depreciation, which represents depreciation
expense net of accelerated depreciation charges, from our adjusted
EBITDA. Our management believes that the adjustment of these items
supplements the GAAP information with a measure that can be used to
assess the sustainability of our operating performance.
- Other (income) expense: The Company has excluded the impact of
pension curtailment (gains) and losses and pension settlements as
such events are triggered by our restructuring and other business
realignment activities and the amount of such charges vary
significantly based on the size and timing of the programs.
Further, we have excluded the change in fair value of the
investment in Wella, as our management believes these unrealized
(gains) and losses do not reflect our underlying ongoing business,
and the adjustment of such impact helps investors and others
compare and analyze performance from period to period. We have
excluded the gain on the exchange of Series B Preferred Stock. Such
transactions do not reflect our operating results and we have
excluded the impact as our management believes that the adjustment
of these items supplements the GAAP information with a measure that
can be used to assess the sustainability of our operating
performance.
- Noncontrolling interest: This adjustment represents the
after-tax impact of the non-GAAP adjustments included in Net income
attributable to noncontrolling interests based on the relevant
noncontrolling interest percentage.
- Tax: This adjustment represents the impact of the tax effect of
the pretax items excluded from Adjusted net income. The tax impact
of the non-GAAP adjustments is based on the tax rates related to
the jurisdiction in which the adjusted items are received or
incurred. Additionally, adjustments are made for the tax impact of
any intra-entity transfer of assets and liabilities.
- Deemed Preferred Stock Dividends: The Company has excluded
preferred stock deemed dividends related to the First Exchange and
the Second Exchange from our calculation of adjusted net income
attributable to Coty Inc. These deemed dividends are non-monetary
in nature, the transactions were entered into to simplify our
capital structure and do not reflect our underlying ongoing
business. Management believes that this adjustment helps investors
and others compare and analyze our performance from period to
period.
The Company has provided a quantitative reconciliation of the
difference between the non-GAAP financial measures and the
financial measures calculated and reported in accordance with GAAP.
For a reconciliation of adjusted gross profit to gross profit,
adjusted EPS (diluted) to EPS (diluted), and adjusted net revenues
to net revenues, see the table entitled “Reconciliation of Reported
to Adjusted Results for the Consolidated Statements of Operations.”
For a reconciliation of adjusted operating income to operating
income and adjusted operating income margin to operating income
margin, see the tables entitled “Reconciliation of Reported
Operating Income (Loss) to Adjusted Operating Income” and
"Reconciliation of Reported Operating Income (Loss) to Adjusted
Operating Income by Segment." For a reconciliation of adjusted
effective tax rate to effective tax rate, see the table entitled
“Reconciliation of Reported Income (Loss) Before Income Taxes and
Effective Tax Rates to Adjusted Income Before Income Taxes and
Adjusted Effective Tax Rates.” For a reconciliation of adjusted net
income and adjusted net income margin to net income (loss), see the
table entitled “Reconciliation of Reported Net Income (Loss) to
Adjusted Net Income.”
The Company also presents free cash flow, adjusted earnings
before interest, taxes, depreciation and amortization ("adjusted
EBITDA"), immediate liquidity, Financial Net Debt and Economic Net
Debt. Management believes that these measures are useful for
investors because it provides them with an important perspective on
the cash available for debt repayment and other strategic measures
and provides them with the same measures that management uses as
the basis for making resource allocation decisions. Free cash flow
is defined as net cash provided by operating activities less
capital expenditures; adjusted EBITDA is defined as adjusted
operating income, excluding adjusted depreciation and non-cash
stock-based compensation. Net debt or Financial Net Debt (which the
Company referred to as "net debt" in prior reporting periods) is
defined as total debt less cash and cash equivalents, and Economic
Net Debt is defined as total debt less cash and cash equivalents
less the value of the Wella Stake. For a reconciliation of Free
Cash Flow, see the table entitled “Reconciliation of Net Cash
Provided by Operating Activities to Free Cash Flow,” for adjusted
EBITDA, see the table entitled “Reconciliation of Adjusted
Operating Income to Adjusted EBITDA” and for Financial Net Debt and
Economic Net Debt, see the tables entitled “Reconciliation of Total
Debt to Financial Net Debt and Economic Net Debt.” Further, our
immediate liquidity is defined as the sum of available cash and
cash equivalents and available borrowings under our Revolving
Credit Facility (please see table "Immediate Liquidity").
These non-GAAP measures should not be considered in isolation,
or as a substitute for, or superior to, financial measures
calculated in accordance with GAAP.
To the extent that the Company provides guidance, it does so
only on a non-GAAP basis and does not provide reconciliations of
such forward-looking non-GAAP measures to GAAP due to the inherent
difficulty in forecasting and quantifying certain amounts that are
necessary for such reconciliation, including adjustments that could
be made for restructuring, integration and acquisition-related
expenses, amortization expenses, non-cash stock-based compensation,
adjustments to inventory, and other charges reflected in our
reconciliation of historic numbers, the amount of which, based on
historical experience, could be significant.
- Tables Follow -
COTY INC. SUPPLEMENTAL SCHEDULES
INCLUDING NON-GAAP FINANCIAL MEASURES
RESULTS AT A GLANCE
Three Months Ended December
31, 2022
Six Months Ended December 31,
2022
(in millions, except per share data)
Change YoY
Change YoY
CONTINUING OPERATIONS
Reported Basis
(LFL)
Reported Basis
(LFL)
Net revenues
$
1,523.6
(3
%)
4
%
$
2,913.6
(1
%)
6
%
Operating income - reported
199.3
(18
%)
371.2
42
%
Operating income - adjusted*
261.4
11
%
511.0
17
%
EBITDA - adjusted
317.6
2
%
625.5
6
%
Net income attributable to common
shareholders - reported**
235.0
24
%
360.3
23
%
Net income attributable to common
shareholders - adjusted* **
191.9
30
%
284.6
35
%
EPS attributable to common shareholders
(diluted) - reported
$
0.27
17
%
$
0.42
17
%
EPS attributable to common shareholders
(diluted) - adjusted*
$
0.22
29
%
$
0.33
27
%
COTY, INC.
Net income attributable to common
shareholders - reported **
235.0
22
%
360.3
22
%
Net income attributable to common
shareholders - adjusted* **
191.9
30
%
284.6
35
%
EPS attributable to common shareholders
(diluted) - reported
$
0.27
17
%
$
0.42
17
%
EPS attributable to common shareholders
(diluted) - adjusted*
$
0.22
29
%
$
0.33
27
%
* These measures, as well as “free cash flow,” “adjusted
earnings before interest, taxes, depreciation and amortization
(adjusted EBITDA),” "immediate liquidity," “financial net debt,”
and "economic net debt" are Non-GAAP Financial Measures. Refer to
“Non-GAAP Financial Measures” for discussion of these measures.
Reconciliations from reported to adjusted results can be found at
the end of this release. ** Net income for Continuing Operations
and Coty Inc. are net of the Convertible Series B Preferred Stock
dividends.
SECOND QUARTER BY SEGMENT (CONTINUING OPERATIONS)
Three Months Ended December
31,
Net Revenues
Change
Reported Operating Income
(Loss)
Adjusted Operating
Income
(in millions)
2022
2021
Reported Basis
LFL
2022
Change
Margin
2022
Change
Margin
Prestige
$
957.7
$
1,008.0
(5%)
3%
$
164.4
16%
17%
$
201.7
11%
21%
Consumer Beauty
565.9
570.2
(1%)
6%
49.4
14%
9%
59.7
10%
11%
Corporate
—
—
N/A
N/A
(14.5
)
<(100%)
N/A
—
N/A
N/A
Total
$
1,523.6
$
1,578.2
(3%)
4%
$
199.3
(18%)
13%
$
261.4
11%
17%
Six Months Ended December
31,
Net Revenues
Change
Reported Operating Income
(Loss)
Adjusted Operating
Income
(in millions)
2022
2021
Reported Basis
LFL
2022
Change
Margin
2022
Change
Margin
Prestige
1,821.2
$
1,878.7
(3%)
5%
$
335.0
22%
18%
$
409.3
14%
22%
Consumer Beauty
1,092.4
1,071.2
2%
9%
81.1
48%
7%
101.7
31%
9%
Corporate
—
—
N/A
N/A
(44.9
)
33%
N/A
—
N/A
N/A
Total
$
2,913.6
$
2,949.9
(1%)
6%
$
371.2
42%
13%
$
511.0
17%
18%
Adjusted EBITDA
Three Months Ended December
31,
Six Months Ended December
31,
(in millions)
2022
2021
2022
2021
Prestige
$
228.5
$
219.0
$
463.6
$
434.1
Consumer Beauty
89.1
92.9
161.9
156.3
Corporate
—
—
—
—
Total
$
317.6
$
311.9
$
625.5
$
590.4
SECOND QUARTER FISCAL 2023 BY REGION
Continuing Operations
Three Months Ended December
31,
Six Months Ended December
31,
Net Revenues
Change
Net Revenues
Change
(in millions)
2022
2021
Reported Basis
LFL
2022
2021
Reported Basis
LFL
Americas
$
624.3
$
587.0
6%
8%
$
1,232.0
$
1,168.5
5%
7%
EMEA
713.5
795.0
(10)%
2%
1,322.7
1,422.1
(7)%
6%
Asia Pacific
185.8
196.2
(5)%
2%
358.9
359.3
—%
6%
Total
$
1,523.6
$
1,578.2
(3)%
4%
$
2,913.6
$
2,949.9
(1) %
6%
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
December 31,
Six Months Ended
December 31,
(in millions, except per share
data)
2022
2021
2022
2021
Net revenues
$
1,523.6
$
1,578.2
$
2,913.6
$
2,949.9
Cost of sales
525.3
561.1
1,026.6
1,065.9
as % of Net revenues
34.5
%
35.6
%
35.2
%
36.1
%
Gross profit
998.3
1,017.1
1,887.0
1,884.0
Gross margin
65.5
%
64.4
%
64.8
%
63.9
%
Selling, general and administrative
expenses
754.3
718.9
1,425.0
1,495.2
as % of Net revenues
49.5
%
45.6
%
48.9
%
50.7
%
Amortization expense
47.6
51.4
94.9
108.4
Restructuring costs
(2.9
)
(4.1
)
(4.1
)
8.3
Acquisition-and divestiture- related
costs
—
6.9
—
10.9
Operating income
199.3
244.0
371.2
261.2
as % of Net revenues
13.1
%
15.5
%
12.7
%
8.9
%
Interest expense, net
61.0
60.9
126.9
120.7
Other income, net
(141.9
)
(126.2
)
(240.1
)
(512.3
)
Income from continuing operations before
income taxes
280.2
309.3
484.4
652.8
as % of Net revenues
18.4
%
19.6
%
16.6
%
22.1
%
Provision for income taxes on continuing
operations
38.8
49.4
108.5
164.0
Net income from continuing operations
241.4
259.9
375.9
488.8
as % of Net revenues
15.8
%
16.5
%
12.9
%
16.6
%
Net income from discontinued
operations
—
3.8
—
3.8
Net income
241.4
263.7
375.9
492.6
Net (loss) income attributable to
noncontrolling interests
(1.4
)
(0.9
)
(1.4
)
(1.4
)
Net income attributable to redeemable
noncontrolling interests
4.5
3.2
10.4
6.6
Net income attributable to Coty Inc.
$
238.3
$
261.4
$
366.9
$
487.4
Amounts attributable to Coty
Inc.
Net income from continuing
operations
$
238.3
$
257.6
$
366.9
$
483.6
Convertible Series B Preferred Stock
dividends
(3.3
)
(68.7
)
(6.6
)
(191.7
)
Net income from continuing operations
attributable to common stockholders
$
235.0
$
188.9
$
360.3
$
291.9
Net income from discontinued
operations
—
3.8
—
3.8
Net income attributable to common
stockholders
$
235.0
$
192.7
$
360.3
$
295.7
Earnings per common share:
Basic for Continuing Operations
$
0.28
$
0.23
$
0.43
$
0.36
Diluted for Continuing Operations(a)
$
0.27
$
0.23
$
0.42
$
0.36
Basic for Coty Inc.
$
0.28
$
0.23
$
0.43
$
0.36
Diluted for Coty Inc.(a)
$
0.27
$
0.23
$
0.42
$
0.36
Weighted-average common shares
outstanding:
Basic
850.8
829.1
846.4
803.3
Diluted(a)(b)
886.8
842.7
884.5
815.1
Depreciation - Continuing Operations
$
56.2
$
78.3
$
115.4
$
159.0
(a)
Adjusted Diluted EPS is adjusted by the effect of dilutive
securities. For the three and six months ended December 31, 2022,
shares for the Forward Repurchase Contracts were excluded from the
computation of adjusted diluted EPS as Coty is in the position to
receive shares from the counterparties and as such their inclusion
would be anti-dilutive. Accordingly, we did not reverse the impact
of the fair market value (gain) for contracts with the option to
settle in shares or cash of ($44.3) and ($6.8), respectively. For
the three months ended December 31, 2022 and 2021, as the
Convertible Series B Preferred Stock was dilutive, an adjustment to
reverse the impact of the preferred stock dividends of $3.3 and
$2.3, respectively, was required. For the six months ended December
31, 2022, as the Convertible Series B Preferred Stock was dilutive,
an adjustment to reverse the impact of the preferred stock
dividends of $6.6 was required. For the six months ended December
31, 2021, the convertible Series B Preferred Stock was
antidilutive. Accordingly, we excluded the convertible Series
B Preferred Stock from the diluted shares and did not adjust the
earnings for the related dividend.
RECONCILIATION OF REPORTED TO ADJUSTED RESULTS FOR THE
CONSOLIDATED STATEMENTS OF OPERATIONS
These supplemental schedules provide adjusted Non-GAAP financial
information and a quantitative reconciliation of the difference
between the Non-GAAP financial measure and the financial measure
calculated and reported in accordance with GAAP.
Three Months Ended December
31, 2022
CONTINUING OPERATIONS
(in millions)
Reported (GAAP)
Adjustments(a)
Adjusted (Non-GAAP)
Net revenues
$
1,523.6
$
—
$
1,523.6
Gross profit
998.3
(0.7
)
997.6
Gross margin
65.5
%
65.5
%
Operating income
199.3
62.1
261.4
as % of Net revenues
13.1
%
17.2
%
Net income
235.0
(43.1
)
191.9
as % of Net revenues
15.4
%
12.6
%
Adjusted EBITDA
317.6
as % of Net revenues
20.8
%
COTY INC.
Net income attributable to Coty
Inc.
235.0
(43.1
)
191.9
EPS (diluted)
$
0.27
$
0.22
Three Months Ended December
31, 2021
CONTINUING OPERATIONS
(in millions)
Reported (GAAP)
Adjustments(a)
Adjusted (Non-GAAP)
Net revenues
$
1,578.2
$
—
$
1,578.2
Gross profit
1,017.1
2.6
1,019.7
Gross margin
64.4
%
64.6
%
Operating income
244.0
(7.7
)
236.3
as % of Net revenues
15.5
%
15.0
%
Net income
188.9
(41.2
)
147.7
as % of Net revenues
12.0
%
9.4
%
Adjusted EBITDA
311.9
as % of Net revenues
19.8
%
COTY INC.
Net income attributable to Coty
Inc.
192.7
(45.0
)
147.7
EPS (diluted)
$
0.23
$
0.17
(a) See “Reconciliation of Reported Operating Income (Loss) to
Adjusted Operated Income” and “Reconciliation of Reported Net
Income to Adjusted Net Income” for a detailed description of
adjusted items.
RECONCILIATION OF REPORTED TO ADJUSTED
RESULTS FOR THE CONSOLIDATED STATEMENTS OF OPERATIONS
These supplemental schedules provide adjusted Non-GAAP financial
information and a quantitative reconciliation of the difference
between the Non-GAAP financial measure and the financial measure
calculated and reported in accordance with GAAP.
Six Months Ended December 31,
2022
CONTINUING OPERATIONS
(in millions)
Reported (GAAP)
Adjustments(a)
Adjusted (Non-GAAP)
Net revenues
$
2,913.6
$
—
$
2,913.6
Gross profit
1,887.0
2.0
1,889.0
Gross margin
64.8
%
64.8
%
Operating income
371.2
139.8
511.0
as % of Net revenues
12.7
%
17.5
%
Net income
360.3
(75.7
)
284.6
as % of Net revenues
12.4
%
9.8
%
Adjusted EBITDA
625.5
as % of Net revenues
21.5
%
COTY INC.
Net income attributable to Coty
Inc.
360.3
(75.7
)
284.6
EPS (diluted)
$
0.42
$
0.33
Six Months Ended December 31,
2021
CONTINUING OPERATIONS
(in millions)
Reported (GAAP)
Adjustments(a)
Adjusted (Non-GAAP)
Net revenues
$
2,949.9
$
—
$
2,949.9
Gross profit
1,884.0
5.3
1,889.3
Gross margin
63.9
%
64.0
%
Operating income
261.2
175.6
436.8
as % of Net revenues
8.9
%
14.8
%
Net income
291.9
(81.1
)
210.8
as % of Net revenues
9.9
%
7.1
%
Adjusted EBITDA
590.4
as % of Net revenues
20.0
%
COTY INC.
Net income attributable to Coty
Inc.
295.7
(84.9
)
210.8
EPS (diluted)
$
0.36
$
0.26
(a) See “Reconciliation of Reported Operating Income (Loss) to
Adjusted Operated Income” and “Reconciliation of Reported Net
Income to Adjusted Net Income” for a detailed description of
adjusted items.
RECONCILIATION OF REPORTED OPERATING INCOME TO ADJUSTED
OPERATING INCOME AND ADJUSTED EBITDA
CONTINUING OPERATIONS
Three Months Ended December
31,
Six Months Ended December
31,
(in millions)
2022
2021
Change
2022
2021
Change
Reported Operating income
$
199.3
$
244.0
(18%)
$
371.2
$
261.2
42%
% of Net revenues
13.1
%
15.5
%
12.7
%
8.9
%
Amortization expense (a)
47.6
51.4
(7%)
94.9
108.4
(12%)
Restructuring and other business
realignment costs (b)
(2.9
)
(1.8
)
(61%)
(3.7
)
13.3
<(100%)
Stock-based compensation
34.2
27.5
24%
65.3
135.7
(52%)
Acquisition- and divestiture-related costs
(c)
—
6.9
(100%)
—
10.9
(100%)
(Gain) on sale of real estate (d)
—
(91.7
)
100%
(1.0
)
(92.7
)
99%
(Gain) related to market exit (e)
(16.8
)
—
N/A
(15.7
)
—
N/A
Total adjustments to reported operating
income
62.1
(7.7
)
>100%
139.8
175.6
(20%)
Adjusted Operating income
$
261.4
$
236.3
11%
$
511.0
$
436.8
17%
% of Net revenues
17.2
%
15.0
%
17.5
%
14.8
%
Adjusted depreciation (f)
56.2
75.6
(26%)
114.5
153.6
(25%)
Adjusted EBITDA
$
317.6
$
311.9
2%
$
625.5
$
590.4
6%
% of Revenues
20.8
%
19.8
%
21.5
%
20.0
%
(a)
In the three months ended
December 31, 2022, amortization expense of $37.3 and $10.3 was
reported in the Prestige and Consumer Beauty segments,
respectively. In the three months ended December 31, 2021,
amortization expense of $40.4 and $11.0 was reported in the
Prestige and Consumer Beauty segments, respectively.
In the six months ended December 31,
2022 , amortization expense of $74.3 and $20.6 was reported in the
Prestige and Consumer Beauty segments, respectively. In the six
months ended December 31, 2021, amortization expense of $85.4
and $23.0 was reported in the Prestige and Consumer Beauty
segments, respectively.
(b)
In the three months ended
December 31, 2022, we incurred a credit in restructuring and
other business structure realignment costs of $(2.9). We incurred a
credit in restructuring costs of $(2.9) primarily related to the
Transformation Plan due to change in estimate, included in the
Condensed Consolidated Statements of Operations; and zero business
structure realignment costs. In the three months ended
December 31, 2021, we incurred a credit in restructuring and
other business structure realignment costs of $(1.8). We incurred a
credit in restructuring costs of $(4.1) primarily related to the
Transformation Plan, included in the Condensed Consolidated
Statements of Operations; and incurred business structure
realignment costs of $2.3 primarily related to the Transformation
Plan and certain other programs. This amount includes $(0.3)
reported in Selling, general and administrative expenses, and $2.6
reported in Cost of sales in the Condensed Consolidated Statement
of Operations.
In the six months ended December 31,
2022, we incurred a credit in restructuring and other business
structure realignment costs of $(3.7). We incurred a credit in
restructuring costs of $(4.1) primarily related to the
Transformation Plan, included in the Condensed Consolidated
Statements of Operations; and business structure realignment costs
of $0.4 primarily related to the Transformation Plan and certain
other programs. This amount includes $0.9 reported in cost of
sales, and $(0.5) reported in selling, general and administrative
expenses in the Condensed Consolidated Statement of Operations. In
the six months ended December 31, 2021, we incurred
restructuring and other business structure realignment costs of
$13.3. We incurred restructuring costs of $8.3 primarily related to
the Transformation Plan, included in the Condensed Consolidated
Statements of Operations; and business structure realignment costs
of $5.0 primarily related to the Transformation Plan and certain
other programs. This amount includes $(0.3) reported in Selling,
general and administrative expenses, and $5.3 reported in Cost of
sales in the Condensed Consolidated Statement of Operations.
(c)
In the three months ended
December 31, 2022 and December 31, 2021, we incurred zero
and $6.9 costs related to acquisition and divestiture activities
respectively. In the three months ended December 31, 2021,
these costs were primarily associated with the Wella
Transaction.
In the six months ended December 31,
2022 and December 31, 2021, we incurred zero and 10.9 costs
related to acquisition and divestiture activities, respectively. In
the six months ended December 31, 2021, these costs were
primarily associated with the Wella Transaction.
(d)
In the three months ended December 31,
2022, we did not recognize any gain related to sale of real estate.
In the three months ended December 31, 2021, we recognized
gains of $91.7 related to sale of real estate.
In the six months ended December 31,
2022, we recognized a gain of $1.0 related to the sale of real
estate. In the six months ended December 31, 2021 we
recognized $92.7 related to sale of real estate.
(e)
In the three months ended December 31,
2022, we recognized gains related to market exit of $16.8, which
are included in Selling, general and administrative expenses and
Cost of sales in the Consolidated Statements of Operations. In the
three months ended December 31, 2021, we did not recognize any
gain related to market exit.
In the six months ended December 31,
2022, we recognized gains related to market exit of $15.7, which
are included in Selling, general and administrative expenses and
Cost of sales in the Consolidated Statements of Operations. In the
six months ended December 31, 2021 we did not recognize any
gain related to market exit.
(f)
In the three months ended
December 31, 2022, adjusted depreciation expense of $26.8 and
$29.4 was reported in the Prestige and Consumer Beauty segments,
respectively. In the three months ended December 31, 2021,
adjusted depreciation expense of $37.0 and $38.6 was reported in
the Prestige and Consumer Beauty segments, respectively.
In the six months ended December 31,
2022, adjusted depreciation expense of $54.3 and $60.2 was reported
in the Prestige and Consumer Beauty segments, respectively. In the
six months ended December 31, 2021, adjusted depreciation
expense of $75.0 and $78.6 was reported in the Prestige and
Consumer Beauty segments, respectively.
RECONCILIATION OF REPORTED INCOME BEFORE INCOME TAXES AND
EFFECTIVE TAX RATES TO ADJUSTED INCOME BEFORE INCOME TAXES AND
ADJUSTED EFFECTIVE TAX RATES FOR CONTINUING OPERATIONS
Three Months Ended December
31, 2022
Three Months Ended December
31, 2021
(in millions)
Income before income
taxes
(Benefit) Provision for income
taxes
Effective tax rate
Income before income
taxes
Provision for income
taxes
Effective tax rate
Reported Income before income taxes -
Continuing Operations
$
280.2
$
38.8
13.8%
$
309.3
$
49.4
16.0%
Adjustments to Reported Operating Income
(a)
62.1
(7.7
)
Change in fair value of investment in
Wella Business (c)
(75.0
)
(128.3
)
Other adjustments (d)
0.2
(3.0
)
Total Adjustments (b)
(12.7
)
28.7
(139.0
)
(33.1
)
Adjusted Income before income taxes -
Continuing Operations
$
267.5
$
67.5
25.2%
$
170.3
$
16.3
9.6%
The adjusted effective tax rate was 25.2% for the three months
ended December 31, 2022 compared to 9.6% for the three months ended
December 31, 2021. The differences were primarily due to a benefit
of $18.8 in the prior period recognized on the revaluation of the
Company's deferred tax assets due to a tax rate increase enacted in
the Netherlands.
Six Months Ended December 31,
2022
Six Months Ended December 31,
2021
(in millions)
Income before income
taxes
(Benefit) Provision for income
taxes
Effective tax rate
Income before income
taxes
Provision for income
taxes
Effective tax rate
Reported Income before income taxes -
Continuing Operations
$
484.4
$
108.5
22.4%
$
652.8
$
164.0
25.1%
Adjustments to Reported Operating Income
(a)
139.8
175.6
Change in fair value of investment in
Wella Business (c)
(210.0
)
(518.3
)
Other adjustments (d)
0.4
(2.8
)
Total Adjustments (b)
(69.8
)
2.5
(345.5
)
(108.0
)
Adjusted Income before income taxes -
Continuing Operations
$
414.6
$
111.0
26.8%
$
307.3
$
56.0
18.2%
The adjusted effective tax rate was 26.8% for the six months
ended December 31, 2022 compared to 18.2% for the six months ended
December 31, 2021. The differences were primarily due to a benefit
of $18.8 in the prior period recognized on the revaluation of the
Company's deferred tax assets due to a tax rate increase enacted in
the Netherlands.
(a)
See a description of adjustments under
“Adjusted Operating Income for Continuing Operations.”
(b)
The tax effects of each of the items
included in adjusted income are calculated in a manner that results
in a corresponding income tax expense/provision for adjusted
income. In preparing the calculation, each adjustment to reported
income is first analyzed to determine if the adjustment has an
income tax consequence. The provision for taxes is then calculated
based on the jurisdiction in which the adjusted items are incurred,
multiplied by the respective statutory rates and offset by the
increase or reversal of any valuation allowances commensurate with
the non-GAAP measure of profitability.
(c)
The amount represents the realized and
unrealized gain recognized for the change in the fair value of the
investment in Wella.
(d)
For the three months ended December 31,
2022, this primarily represents adjustments for equity loss from
KKW. For the three months ended December 31, 2021, this primarily
represents a net gain on the exchange of Series B Preferred Stock
closed on October 20, 2021.
For the six months ended December 31,
2022, this primarily represents adjustments for equity loss from
KKW. For the six months ended December 31, 2021, this primarily
represents a net gain on the exchange of Series B Preferred Stock
closed on October 20, 2021.
RECONCILIATION OF REPORTED NET INCOME TO ADJUSTED NET INCOME
FOR CONTINUING OPERATIONS
Three Months Ended December
31,
Six Months Ended December
31,
(in millions)
2022
2021
Change
2022
2021
Change
Net income from Continuing Operations, net
of noncontrolling interests
$
238.3
$
257.6
(7)%
$
366.9
$
483.6
(24)%
Convertible Series B Preferred Stock
dividends (c)
(3.3
)
(68.7
)
95%
(6.6
)
(191.7
)
97%
Reported Net income attributable to
Continuing Operations
$
235.0
$
188.9
24%
$
360.3
$
291.9
23%
% of Net revenues
15.4
%
12.0
%
12.4
%
9.9
%
Adjustments to Reported Operating Income
(a)
62.1
(7.7
)
>100%
139.8
175.6
(20%)
Change in fair value of investment in
Wella Business (d)
(75.0
)
(128.3
)
42%
(210.0
)
(518.3
)
59%
Adjustments to other (income) expense
(e)
0.2
(3.0
)
>100%
0.4
(2.8
)
>100%
Adjustments to noncontrolling interest
expense (b)
(1.7
)
(1.7
)
0%
(3.4
)
(3.6
)
6%
Change in tax provision due to adjustments
to Reported Net income attributable to Continuing Operations
(28.7
)
33.1
<(100%)
(2.5
)
108.0
<(100%)
Adjustment for deemed Series B Preferred
Stock dividends related to the First and Second Exchanges (c)
(f)
—
66.4
(100%)
—
160.0
(100%)
Adjusted Net income attributable to
Continuing Operations
$
191.9
$
147.7
30%
$
284.6
$
210.8
35%
% of Net revenues
12.6
%
9.4
%
9.8
%
7.1
%
Per Share Data
Adjusted weighted-average common
shares
Basic
850.8
829.1
846.4
803.3
Diluted (c) (f)
886.8
892.3
884.5
815.1
Adjusted Net income attributable to
Continuing Operations per Common Share
Basic
$
0.23
$
0.18
$
0.34
$
0.26
Diluted (c)
$
0.22
$
0.17
$
0.33
$
0.26
(a)
See a description of adjustments under
“Adjusted Operating Income for Continuing Operations.”
(b)
The amounts represent the after-tax impact
of the non-GAAP adjustments included in Net income attributable to
noncontrolling interest based on the relevant noncontrolling
interest percentage in the Condensed Consolidated Statements of
Operations.
(c)
Adjusted Diluted EPS is adjusted by the
effect of dilutive securities. For the three and six months ended
December 31, 2022, shares for the Forward Repurchase Contracts were
excluded from the computation of adjusted diluted EPS as Coty is in
the position to receive shares from the counterparties and as such
their inclusion would be anti-dilutive. Accordingly, we did not
reverse the impact of the fair market value (gain) for contracts
with the option to settle in shares or cash of ($44.3) and ($6.8),
respectively. For the three months ended December 31, 2022 and
2021, as the Convertible Series B Preferred Stock was dilutive, an
adjustment to reverse the impact of the preferred stock dividends
of $3.3 and $2.3, respectively, was required. For the six months
ended December 31, 2022, as the Convertible Series B Preferred
Stock was dilutive, an adjustment to reverse the impact of the
preferred stock dividends of $6.6 was required. For the six months
ended December 31, 2021, the convertible Series B Preferred Stock
was antidilutive. Accordingly, we excluded the convertible
Series B Preferred Stock from the diluted shares and did not adjust
the earnings for the related dividend.
(d)
The amount represents the realized and
unrealized gain recognized for the change in the fair value of the
investment in Wella.
(e)
For the three months ended December 31,
2022, this primarily represents adjustments for equity loss
from KKW. For the three months ended December 31, 2021, this
primarily represents a net gain on the exchange of Series B
Preferred Stock closed on October 20, 2021
For the six months ended December 31, 2022
, this primarily represents adjustments for equity loss from KKW.
For the six months ended December 31, 2021, this primarily
represents a net gain on the exchange of Series B Preferred Stock
closed on October 20, 2021.
(f)
For the three months ended December 31,
2021, this adjustment represents the deemed dividend from the
Second Exchange that closed on November 30, 2021.
For the six months ended December 31,
2021, this adjustment represents the deemed dividend from the
Second Exchange that closed on November 30, 2021 and the deemed
dividend from the First Exchange that closed on October 20,
2021.
RECONCILIATION OF REPORTED NET INCOME TO ADJUSTED NET INCOME
FOR COTY INC.
Three Months Ended December
31,
Six Months Ended December
31,
(in millions)
2022
2021
Change
2022
2021
Change
Net income from Coty Inc., net of
noncontrolling interests
$
238.3
$
261.4
(9%)
$
366.9
$
487.4
(25%)
Convertible Series B Preferred Stock
dividends (c)
(3.3
)
(68.7
)
95%
(6.6
)
(191.7
)
97%
Reported Net income attributable to
Coty Inc.
$
235.0
$
192.7
22%
$
360.3
$
295.7
22%
% of Net revenues
15.4
%
12.2
%
12.4
%
10.0
%
Adjustments to Reported Operating income
(a)
62.1
(7.7
)
>100%
139.8
175.6
(20%)
Adjustments to loss on sale of business
(g)
—
(4.8
)
100%
—
(4.8
)
100%
Change in fair value of investment in
Wella Business (d)
(75.0
)
(128.3
)
42%
(210.0
)
(518.3
)
59%
Adjustments to other expense (e)
0.2
(3.0
)
>100%
0.4
(2.8
)
>100%
Adjustments to noncontrolling interests
(b)
(1.7
)
(1.7
)
0%
(3.4
)
(3.6
)
6%
Change in tax provision due to adjustments
to Reported Net income attributable to Coty Inc.
(28.7
)
34.1
<(100%)
(2.5
)
109.0
<(100%)
Adjustment for deemed Series B Preferred
Stock dividends related to the First and Second Exchanges
(c)(f)
—
66.4
(100%)
—
160.0
(100%)
Adjusted Net income attributable to
Coty Inc.
$
191.9
$
147.7
30%
$
284.6
$
210.8
35%
Per Share Data
Adjusted weighted-average common
shares
Basic
850.8
829.1
846.4
803.3
Diluted (c)
886.8
892.3
884.5
815.1
Adjusted Net income attributable to
Coty Inc. per Common Share
Basic
$
0.23
$
0.18
$
0.34
$
0.26
Diluted (c)
$
0.22
$
0.17
$
0.33
$
0.26
(a)
See a description of adjustments under
“Adjusted Operating Income (loss) for Coty Inc.”
(b)
The amounts represent the after-tax impact
of the non-GAAP adjustments included in Net income attributable to
noncontrolling interest based on the relevant noncontrolling
interest percentage in the Condensed Consolidated Statements of
Operations.
(c)
Adjusted Diluted EPS is adjusted by the
effect of dilutive securities. For the three and six months ended
December 31, 2022, shares for the Forward Repurchase Contracts were
excluded from the computation of adjusted diluted EPS as Coty is in
the position to receive shares from the counterparties and as such
their inclusion would be anti-dilutive. Accordingly, we did not
reverse the impact of the fair market value (gain) for contracts
with the option to settle in shares or cash of ($44.3) and ($6.8),
respectively. For the three months ended December 31, 2022 and
2021, as the Convertible Series B Preferred Stock was dilutive, an
adjustment to reverse the impact of the preferred stock dividends
of $3.3 and $2.3, respectively, was required. For the six months
ended December 31, 2022, as the Convertible Series B Preferred
Stock was dilutive, an adjustment to reverse the impact of the
preferred stock dividends of $6.6 was required. For the six months
ended December 31, 2021, the convertible Series B Preferred Stock
was antidilutive. Accordingly, we excluded the convertible
Series B Preferred Stock from the diluted shares and did not adjust
the earnings for the related dividend.
(d)
The amount represents the realized and
unrealized gain recognized for the change in the fair value of the
investment in Wella.
(e)
For the three months ended December 31,
2022, this primarily represents the loss from equity investment in
KKW. For the three months ended December 31, 2021, this primarily
represents a net gain on the exchange of Series B Preferred Stock
closed on October 20, 2021.
For the six months ended December 31,
2022, this primarily represents the loss from equity investment in
KKW. For the six months ended December 31, 2021, this primarily
represents a net gain on the exchange of Series B Preferred Stock
closed on October 20, 2021.
(f)
For the three months ended December 31,
2021, this adjustment represents the deemed dividend from the
Second Exchange that closed on November 30, 2021.
For the six months ended December 31,
2021, this adjustment represents the deemed dividend from the
Second Exchange that closed on November 30, 2021 and the deemed
dividend from the First Exchange that closed on October 20,
2021.
(g)
This amount reflects certain working
capital adjustments related to the sale of the Wella business.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES
TO FREE CASH FLOW
COTY INC.
Three Months Ended December
31,
Six Months Ended December
31,
(in millions)
2022
2021
2022
2021
Net cash provided by operating
activities
$
482.2
$
449.0
$
645.4
$
734.7
Capital expenditures
(27.1
)
(41.0
)
(102.1
)
(86.0
)
Free cash flow
$
455.1
$
408.0
$
543.3
$
648.7
RECONCILIATION OF TOTAL DEBT TO ECONOMIC NET DEBT
COTY INC.
As of
(in millions)
December 31, 2022
Total debt
$
4,137.9
Less: Cash and cash equivalents
280.8
Financial Net debt
$
3,857.1
Less: Value of Wella stake
1,040.0
Economic Net debt
$
2,817.1
IMMEDIATE LIQUIDITY
COTY INC.
As of
(in millions)
December 31, 2022
Cash and cash equivalents
$
280.8
Unutilized revolving credit facility
1,914.9
Immediate Liquidity
$
2,195.7
RECONCILIATION OF ADJUSTED OPERATING INCOME TO ADJUSTED
EBITDA
Twelve months ended
December 31, 2022
(in millions)
CONTINUING OPERATIONS
Adjusted operating income (a)
$
689.8
Add: Adjusted depreciation(b)
250.7
Adjusted EBITDA
$
940.5
(a)
Adjusted operating income for the twelve months ended
December 31, 2022 represents the summation of the adjusted
operating income (loss) for continuing operations for each of the
quarters ended March 31, 2022, June 30, 2022, September 30, 2022,
and December 31, 2022. For a reconciliation of adjusted operating
income (loss) to operating income (loss) for continuing operations
for each of those periods, see the table entitled “Reconciliation
of Reported Operating Income (loss) to Adjusted Operating Income
for Continuing Operations” for each of those periods.
(b)
Adjusted depreciation for the twelve months ended
December 31, 2022 represents depreciation expense for
continuing operations for the period, excluding accelerated
depreciation.
FINANCIAL NET DEBT/ADJUSTED EBITDA
December 31, 2022
Financial Net Debt - Coty Inc.
$
3,857.1
Adjusted EBITDA - Continuing
operations
940.5
Financial Net Debt/Adjusted
EBITDA
4.10
RECONCILIATION OF REPORTED NET REVENUES TO LIKE-FOR-LIKE NET
REVENUES
Three Months Ended December
31, 2022 vs. Three Months Ended December 31, 2021 Net
Revenue Change
Net Revenues Change YoY
Reported Basis
Constant Currency
Impact from Acquisitions and
Divestitures
LFL
Prestige
(5)%
3%
—%
3%
Consumer Beauty
(1)%
6%
—%
6%
Total Continuing Operations
(3)%
4%
—%
4%
Six Months Ended December 31,
2022 vs. Six Months Ended December 31, 2021 Net Revenue
Change
Net Revenues Change YoY
Reported Basis
Constant Currency
Impact from Acquisitions and
Divestitures
LFL
Prestige
(3)%
5%
—%
5%
Consumer Beauty
2%
9%
—%
9%
Total Continuing Operations
(1)%
6%
—%
6%
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions)
December 31,
2022
June 30, 2022
ASSETS
Current assets:
Cash and cash equivalents
$
280.8
$
233.3
Restricted cash
31.5
30.5
Trade receivables, net
433.8
364.6
Inventories
718.2
661.5
Prepaid expenses and other current
assets
442.0
392.0
Total current assets
1,906.3
1,681.9
Property and equipment, net
688.7
715.5
Goodwill
3,920.3
3,914.7
Other intangible assets, net
3,848.0
3,902.8
Equity investments
1,050.6
842.6
Operating lease right-of-use assets
301.5
320.9
Other noncurrent assets
739.2
737.7
TOTAL ASSETS
$
12,454.6
$
12,116.1
LIABILITIES, MEZZANINE EQUITY AND
STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
1,489.7
$
1,268.3
Short-term debt and current portion of
long-term debt
68.1
23.0
Other current liabilities
1,357.8
1,274.3
Total current liabilities
2,915.6
2,565.6
Long-term debt, net
4,014.0
4,409.1
Long-term operating lease liabilities
265.2
282.2
Other noncurrent liabilities
1,326.1
1,301.2
TOTAL LIABILITIES
8,520.9
8,558.1
CONVERTIBLE SERIES B PREFERRED
STOCK
142.4
142.4
REDEEMABLE NONCONTROLLING
INTERESTS
69.7
69.8
Total Coty Inc. stockholders’
equity
3,531.4
3,154.5
Noncontrolling interests
190.2
191.3
Total equity
3,721.6
3,345.8
TOTAL LIABILITIES, MEZZANINE EQUITY AND
STOCKHOLDERS’ EQUITY
$
12,454.6
$
12,116.1
COTY INC. & SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Six Months Ended
December 31,
2022
2021
CASH FLOWS FROM OPERATING
ACTIVITIES:
Net income
$
375.9
492.6
Adjustments to reconcile net income (loss)
to net cash provided by operating activities:
Depreciation and amortization
210.4
267.6
Non-cash lease expense
32.1
36.6
Deferred income taxes
84.6
99.4
Provision (releases) for bad debts
(15.8
)
1.1
Provision for pension and other
post-employment benefits
4.6
8.5
Share-based compensation
65.3
135.8
Losses (gains) on disposals of long-term
assets, net
4.7
(91.1
)
Gain on sale of business in discontinued
operations
—
(4.8
)
Realized and unrealized gains from equity
investments, net
(208.0
)
(516.9
)
Other
19.0
6.1
Change in operating assets and
liabilities, net of effects from purchase of acquired
companies:
Trade receivables
(45.7
)
(188.7
)
Inventories
(55.3
)
40.2
Prepaid expenses and other current
assets
(55.2
)
(101.5
)
Accounts payable
227.2
257.1
Accrued expenses and other current
liabilities
75.1
271.8
Operating lease liabilities
(33.5
)
(40.2
)
Other assets and liabilities, net
(40.0
)
61.1
Net cash provided by operating
activities
645.4
734.7
CASH FLOWS FROM INVESTING
ACTIVITIES:
Capital expenditures
(102.1
)
(86.0
)
Proceeds from sale of long-term assets and
license terminations
56.9
126.5
Proceeds from contingent consideration
from sale of discontinued business
—
34.0
Net cash used in investing
activities
(45.2
)
74.5
CASH FLOWS FROM FINANCING
ACTIVITIES:
Proceeds from revolving loan
facilities
612.0
444.3
Repayments of revolving loan
facilities
(806.1
)
(1,114.7
)
Proceeds from issuance of other long-term
debt
—
500.0
Repayments of term loans and other long
term debt
(188.6
)
(212.2
)
Dividend payment on Class A Common Stock
and Class B Preferred Stock
(7.1
)
(50.4
)
Net (repayments for) proceeds from foreign
currency contracts
(133.5
)
(50.8
)
Purchase of remaining mandatorily
redeemable noncontrolling interest
—
(7.1
)
Distributions to noncontrolling interests,
redeemable noncontrolling interests and mandatorily redeemable
financial instruments
—
(8.5
)
Payment of deferred financing fees
—
(37.2
)
All other
(13.3
)
(10.9
)
Net cash provided by financing
activities
(536.6
)
(547.5
)
EFFECT OF EXCHANGE RATES ON CASH, CASH
EQUIVALENTS AND RESTRICTED CASH
(15.1
)
(9.6
)
NET (DECREASE)/INCREASE IN CASH, CASH
EQUIVALENTS AND RESTRICTED CASH
48.5
252.1
CASH, CASH EQUIVALENTS AND RESTRICTED
CASH—Beginning of period
263.8
310.4
CASH, CASH EQUIVALENTS AND RESTRICTED
CASH—End of period
$
312.3
$
562.5
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230208005134/en/
Investor Relations Olga
Levinzon, +1 212 389-7733 olga_levinzon@cotyinc.com
Media Antonia Werther,
+31 621 394495 Antonia_Werther@cotyinc.com
Coty (NYSE:COTY)
Gráfico Histórico do Ativo
De Abr 2023 até Mai 2023
Coty (NYSE:COTY)
Gráfico Histórico do Ativo
De Mai 2022 até Mai 2023